1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. HOME INFUSION THERAPY MARKET BY PRODUCT TYPE
5.1. Introduction
5.2. Infusion Pumps
5.3. Infusion Catheters
5.4. Intravenous IV Sets
5.5. Others
6. HOME INFUSION THERAPY MARKET BY ROUTE OF ADMINISTRATION
6.1. Introduction
6.2. Intravenous
6.3. Subcutaneous
7. HOME INFUSION THERAPY MARKET BY APPLICATION
7.1. Introduction
7.2. Anti-Infective Therapy
7.3. Parenteral Nutrition
7.4. Chemotherapy
7.5. Pain Management Drugs
7.6. Hydration Therapy
7.7. Others
8. HOME INFUSION THERAPY MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Product Type
8.2.2. By Route of Administration
8.2.3. By Application
8.2.4. By Country
8.2.4.1. USA
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. By Product Type
8.3.2. By Route of Administration
8.3.3. By Application
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. By Product Type
8.4.2. By Route of Administration
8.4.3. By Application
8.4.4. By Country
8.4.4.1. Germany
8.4.4.2. France
8.4.4.3. United Kingdom
8.4.4.4. Spain
8.4.4.5. Others
8.5. Middle East and Africa
8.5.1. By Product Type
8.5.2. By Route of Administration
8.5.3. By Application
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.2. UAE
8.5.4.3. Israel
8.5.4.4. Others
8.6. Asia Pacific
8.6.1. By Product Type
8.6.2. By Route of Administration
8.6.3. By Application
8.6.4. By Country
8.6.4.1. China
8.6.4.2. India
8.6.4.3. Japan
8.6.4.4. South Korea
8.6.4.5. Indonesia
8.6.4.6. Thailand
8.6.4.7. Taiwan
8.6.4.8. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. B. Braun SE
10.2. Baxter International Inc.
10.3. Becton Dickinson Company
10.4. Fresenius Kabi
10.5. ICU Medical Inc.
10.6. Terumo Corporation
10.7. Nipro Corporation
10.8. KORU Medical Systems
10.9. CODAN Companies
10.10. BPL Medical Technologies
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES